Allen's son, Wesley, was diagnosed with acute promyelocytic leukemia in January 2025. Hines-Allen missed a game d ...

Jaguars defensive end Josh Hines-Allen said his seven-year-old son, Wesley, is in remission after fighting acute ...

Jacksonville Jaguars DE Josh Hines-Allen disclosed his son's pediatric cancer diagnosis and the his campaign for ...

Acute promyelocytic leukemia (APL) is a unique subtype of acute myeloid leukemia (AML). The prognosis of APL is changing, from the worst among AML as it used to be, to currently the best. The ...

In a heartfelt announcement, Jacksonville Jaguars defensive end Josh Hines-Allen has shared that his 7-year-old son, Wesley, ...

Jacksonville Jaguars defensive end Josh Hines-Allen announced Friday that his 7-year-old son, Wesley, is recovering from ...

Acute promyelocytic leukemia (APL) is one of the commonest subtypes of acute myeloid leukemia (AML) and has been of particular interest given that it is the first disease for which molecularly ...

Oncotarget Volume 11, Issue 11 reported that relapsed APL, particularly in the high-risk subset of patients, remains an important clinical problem. The probability of relapse is significantly ...

"Remarkable" results with a novel treatment regimen in pediatric acute promyelocytic leukemia (APL) have been reported by researchers at the National Cancer Institute (NCI). Two-year event free ...

Acute promyelocytic leukemia (APL) is a subtype of acute myeloid leukemia (AML) that accounts for 10–15% of the approximately 12,330 adults diagnosed with AML in the USA each year. [1] ...

Video: In Acute Promyelocytic Leukemia, Using Corticosteroids for Differentiation Syndrome —Dr. Lai, of the University of Pennsylvania, believes steroids are "very effective" for both the ...

Acute promyelocytic leukemia (APL) is rare in children. All- trans -retinoic acid (ATRA) combined with chemotherapy, the reference treatment of APL, is generally considered to produce similar results ...